LUBRIS BIOPHARMA
Lµbris BioPharma is a development-stage life science company producing and commercializing a version of the human protein, lubricin.
LUBRIS BIOPHARMA
Industry:
Biotechnology Health Care
Founded:
2011-01-01
Address:
Weston, Massachusetts, United States
Country:
United States
Website Url:
http://www.lubris.net
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt WordPress Font Awesome Apache Wordpress Plugins IPv6
Similar Organizations
Beta Pharma
Beta Pharma is an emerging pharmaceutical company dedicated to the discovery,and commercialization of innovative late stage therapies
Kite Pharma
Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications..
Investors List
Thynk Capital, LLC.
Thynk Capital, LLC. investment in Series A - Lubris BioPharma
More informations about "Lubris BioPharma"
Lubris BioPharma
Lµbris BioPharma is a biopharmaceutical company developing recombinant human lubricin for the treatment of dry eye, osteoarthritis and other age & inflammation-related conditions. Lubricin …See details»
Lubris BioPharma - Crunchbase Company Profile & Funding
Lubris BioPharma is a biopharmaceutical company developing recombinant human lubricin for the treatment of dry eye, osteoarthritis, and other age and inflammation-related conditions. it is …See details»
about - Lubris BioPharma
Lµbris BioPharma is a development-stage life science company producing and commercializing a recombinant version of the human protein, lubricin. Lubricin is expressed in numerous parts of …See details»
Lubris LLC | Who We Are - Lubris BioPharma
Lubris, LLC, is developing recombinant human lubricin, a proprietary version of the human protein Lubricin, also referred to as PRG4 (proteoglycan 4). Lubricin is an endogenous protein found …See details»
Lubris BioPharma - LinkedIn
Lµbris BioPharma is a biopharmaceutical company developing recombinant human lubricin for the treatment of dry eye, osteoarthritis and other age & inflammation-related conditions.See details»
Lµbris BioPharma - VentureRadar
Lubris BioPharma is a development-stage life science company producing and commercializing a recombinant version of the human protein, lubricin. Lubricin is expressed in numerous parts of …See details»
Lµbris BioPharma - VentureRadar
Website: http://lubris.net/ Develops recombinant human lubricin treatments for various age and inflammation-related conditions, including dry eye and osteoarthritis, in the biopharmaceutical …See details»
Lubris BioPharma - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Lubris BioPharma. Use the PitchBook Platform to explore the full profile.See details»
Lubris BioPharma - Products, Competitors, Financials, Employees ...
Lubris BioPharma is a biopharmaceutical company focused on developing recombinant human lubricin for various medical conditions. Use the CB Insights Platform to explore Lubris …See details»
Lubris BioPharma - Contacts, Employees, Board Members
Lubris BioPharma has 7 current employee profiles, including Co-founder and CEO Edward Truitt. Lµbris BioPharma is a development-stage life science company producing and …See details»
Lubris LLC | What We Do
Lubris, LLC, is dedicated to the development and commercialization of recombinant human lubricin, a proprietary recombinant form of the human protein Lubricin to treat a wide variety of age and inflammation related conditions, …See details»
Lubris Announces Outlicensing Of Its Proprietary Recombinant …
BOSTON, April 6, 2017 /PRNewswire/ -- Lµbris BioPharma announced today that Novartis has exercised an option to in-license ECF843, Lµbris' proprietary recombinant human lubricin for …See details»
Selexis Lubris Partnership Advances Difficult-to-Express Protein ...
Jun 27, 2012 · LUB-13-04 is a proprietary construct of the recombinant human protein lubricin (Proteoglycan 4 protein, rLubricin) which is expressed from the SURE CHO-M cell line …See details»
Novartis to strengthen R&D pipeline by in-licensing ECF843 for ...
Apr 6, 2017 · ECF843 is a recombinant human lubricin (rh-Lubricin) protein, developed by Lubris LLC, Boston, USA. Instant relief of dry eye symptoms by improving signs in a timely manner …See details»
Lubricin Data Demonstrates Significant Improvement in Multiple …
Sep 20, 2016 · Lµbris BioPharma is a biopharmaceutical company developing recombinant human lubricin for the treatment of dry eye, osteoarthritis and other age & inflammation-related …See details»
contact | Lubris BioPharma
For partnership opportunities or general questions, please contact Harry Barnett at [email protected].See details»
Lubris Announces Outlicensing Of Its Proprietary Recombinant …
BOSTON, April 6, 2017 /PRNewswire/ -- Lµbris BioPharma announced today that Novartis has exercised an option to in-license ECF843, Lµbris' proprietary recombinant human lubricin for …See details»
Commercial Partners & Licensing - Lubris BioPharma
A cornerstone of Lµbris BioPharma’s commercialization plan is the establishment of partnerships, joint ventures and licensing arrangements with other innovative and successful companies, …See details»
Selexis Lubris Partnership Advances Difficult-to-Express Protein ...
Jun 27, 2012 · LUB-13-04 is a proprietary construct of the recombinant human protein lubricin (Proteoglycan 4 protein, rLubricin) which is expressed from the SURE CHO-M cell line …See details»
about Lubricin - Lubris BioPharma
Lubricin (PRG4) is a large endogenous complex glycoprotein that binds to, and protects tissue surfaces from friction induced wear & damage in much the same way that Teflon® coats and …See details»